Latest Cartilage Stories
Growing up in the south, one tends to hear the older generation talk about “Arthur.” But, the “Arthur” they’re speaking of is not a person at all.
Henry Ford Hospital researchers have identified for the first time two molecules that hold promise as a biomarker for measuring cartilage damage associated with osteoarthritis.
A man-made package filled with nature's bone-building ingredients delivers the goods over time and space to heal serious bone injuries faster than products currently available.
A lab discovery is a step toward implantable replacement cartilage, holding promise for knees, shoulders, ears and noses damaged by osteoarthritis, sports injuries and accidents.
In a study to be published online Nov. 6 in Nature Medicine, investigators at the Stanford University School of Medicine have shown that the development of osteoarthritis is in great part driven by low-grade inflammatory processes.
A novel study demonstrates that using nanoparticles to deliver osteoarthritis drugs to the knee joint could help increase the retention of the drug in the knee cavity, and therefore reduce the frequency of injections patients must receive.
A blast of gamma radiation could toughen up plastic prosthetic joints to make them strong enough to last for years.
A medication already approved to build bone mass in patients with osteoporosis also builds cartilage around joints and could potentially be repurposed to treat millions of people suffering from arthritis.
- Growing in low tufty patches.